When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOK - MyoKardia's MYK-491 shows positive effect in certain heart failure patients
MyoKardia Inc.
MyoKardia (MYOK-0.5%) announces positive preliminary data from a Phase 2a clinical trial evaluating MYK-491 in patients with stable heart failure due to the inability of the left ventricle to pump blood effectively.
More news on: MyoKardia, Inc., Healthcare stocks news,